Invitae Epilepsy Panel
Analyzes key genes linked to syndromic and nonsyndromic epilepsy to support diagnosis, clarify prognosis, guide care, and inform family counseling.
Accessed through the Invitae Unlock™ Sponsored Testing Program•Sponsored by Invitae | Labcorp•Performed by Invitae | Labcorp
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.
When to consider this test
Patient selection
- Patients under 18 with a history of at least one unprovoked seizure.
Workflow
How to use this program
- 1
Submit an order
Place the order online or via paper TRF. Include the patient’s insurance information for benefits investigation.
- 2
Collect specimen
Collect a blood, buccal, or saliva specimen using a Labcorp kit and follow standard collection procedures.
- 3
Receive results
Turnaround time is typically 10–21 days from specimen receipt. Results will be available through your Labcorp portal.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Invitae | Labcorp, a CLIA-certified laboratory (CLIA 05D2040778). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
What is the purpose of this program?
The program provides genetic testing for pediatric patients (<18 years) with at least one unprovoked seizure. It is designed to help clarify etiology, inform management, and support family counseling.
Who qualifies for testing?
Patients under 18 who have experienced an unprovoked seizure meet program eligibility.
Which panel is used?
The program uses a curated epilepsy gene panel that includes well-established syndromic and nonsyndromic causes of pediatric seizures.
How do I order the test?
Ordering is completed through the sponsoring lab’s requisition workflow. Providers must submit the order and ensure appropriate sample collection.
What is the turnaround time?
The average turnaround time is 10–21 days from specimen receipt.
How is billing handled?
Labcorp assesses insurance coverage and will bill the payer after results are released. If the patient is uninsured, not covered, or does not meet payer criteria, the family may qualify for sponsored, no-charge testing. De-identified patient and clinician information may be shared with approved third parties regardless of billing route.
Where are results sent?
Results are delivered directly to the ordering provider. It is the provider’s responsibility to interpret findings and counsel the family.
See an issue with this program?